Back to Trades
Baynes Roy D.
InsiderCIK 0001680739
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 13
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 4
- Active
- 2025–2026
Across 13 filings between 2025–2026, Baynes Roy D. has disclosed $7.2M in transactions — spread across 4 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $2.5M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Jun 30 | NTRA Natera, Inc. | Baynes Roy D. | Insider | Grant | $0 |
| Jun 16 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. | Insider | Sell | $225.0K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Baynes Roy D. | Director | Award | $495.6K |
| May 6 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. | Insider | Sell | $209.9K |
| May 4 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. | Insider | Sell | $431.1K |
| Apr 28 | NTRA Natera, Inc. | Baynes Roy D. | Insider | Grant | $0 |
| Apr 16 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. | Insider | Sell | $1.4M |
| Apr 7 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. | Insider | Sell | $330.0K |
| Mar 4 | EIKN Eikon Therapeutics, Inc. | Baynes Roy D. | Insider | Award | $2.0M |
| Feb 4 | EIKN Eikon Therapeutics, Inc. | Baynes Roy D. | Insider | Other | $0 |
| Feb 3 | NTRA Natera, Inc. | Baynes Roy D. | Insider | Grant | $0 |
| Nov 4 | NTRA Natera, Inc. | Baynes Roy D. | Insider | Grant | $0 |
| Jul 29 | NTRA Natera, Inc. | Baynes Roy D. | Insider | Grant | $0 |
13 filings